Associate Professor Houssami is a Public Health Physician/Clinical Epidemiologist, a Breast Physician, and a clinical researcher, who has worked in breast cancer for over 20 years. Both her clinical practice and her research focus on breast diagnosis and specifically breast imaging and screening, and much of her research is aimed at supporting evidence-based practice in breast diagnosis. Her expertise encompasses population breast screening, high-risk screening, breast diagnostic testing and prognostic testing, imaging-based intervention, and the effect of tests on clinical outcomes. She has experience in research design in test evaluation, and in systematic evidence reviews in breast cancer, and has an established national and international reputation in breast imaging and diagnostic studies and in meta-analysis. She has over 110 peer-reviewed publications that have included papers in leading medical journals (JAMA, CA, JCO, and Lancet Oncology), and meta-analyses on new breast imaging technologies that have been highly-cited and have been recognized through invited international presentations. She currently leads or co-leads studies of MRI in preoperative assessment, MRI in monitoring response to neoadjuvant therapy, a population-based study of metastatic breast cancer in NSW women, an evaluation of the association of tumour subtype with pCR in neoadjuvant therapy, and an international trial of tomosynthesis in breast screening. She is the section editor for Imaging, Screening & Diagnosis with The Breast, and is lead of the breast cancer research portfolio as part the Screening & Test Evaluation Program (Sydney Medical School). She has previously held roles as Medical Director of the Sydney Breast Clinic, and as Associate Clinical Director, NSW Breast Cancer Institute, and is currently a consultant clinician at the NSW Women’s Breast Centre, Royal Hospital for Women.